Additional Chalcogen Double Bonded Directly To Ring Carbon Of The Hetero Ring Patents (Class 540/518)
  • Patent number: 5580895
    Abstract: The present invention relates to compounds of formula (I) which are antagonists of gastrin and CCK-B receptors. The compounds of formula (I) are 1,5-benzodiazepine derivatives.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: December 3, 1996
    Assignee: Glaxo SpA
    Inventors: Harry Finch, David G. Trist, Giorgio Tarzia, Aldo Feriani
  • Patent number: 5521170
    Abstract: Compounds having the structure below ##STR1## and pharmaceutically acceptable salts thereof exhibit vasopressin antagonistic activity, vasodilating activity, hypotensive activity, activity for inhibiting saccharide release in the liver, activity for inhibiting growth of mesagium cells, water diuretic activity, platelet agglutination inhibitory activity, oxytocin antagonistic activity and the like, and are useful in treating or preventing hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome, hepatocirrhosis, hyponatremia, hypokalemia, diabetic or circulation disorder, oxytocin related diseases and the like.
    Type: Grant
    Filed: March 31, 1994
    Date of Patent: May 28, 1996
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Hiroyuki Setoi, Takehiko Ohkawa, Tatsuya Zenkoh, Keiji Hemmi, Hirokazu Tanaka
  • Patent number: 5510480
    Abstract: The invention encompasses compounds of the formula: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof wherein n is 0, 1, or 2, X is ##STR2## Z is H.sub.2, oxygen or sulfur, and R.sub.1, R.sub.2, R.sub.3, R.sub.4, T, W, and Y are defined variables.These compounds are highly selective agonists or inverse agonists for the GABAa brain receptors and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepinc type drugs, and enhancement of alertness.
    Type: Grant
    Filed: July 11, 1994
    Date of Patent: April 23, 1996
    Assignee: Neurogen Corporation
    Inventor: Pamela Albaugh
  • Patent number: 5486514
    Abstract: The present invention relates to compound of formula (I) which are antagonists of gastrin and CCK-B receptors. The compounds of formula (I) are carbamate derivatives.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: January 23, 1996
    Assignee: Glaxo SpA
    Inventors: David Trist, Giorgio Pentassuglia, Maria E. Tranquillini, Antonella Ursini
  • Patent number: 4988692
    Abstract: A compound in all possible isomeric forms and mixtures thereof of the formula ##STR1## wherein X and X' are individually selected from the group consisting of hydrogen, halogen, cyano, --NO.sub.2, --CF.sub.3 and alkyl and alkoxy of 1 to 8 carbon atoms, R is hydrogen or alkyl of 1 to 8 carbon atoms and Ar is selected from the group consisting of an unsubstituted or substituted aryl of 6 to 14 carbon atoms, an unsubstituted or substituted aromatic heterocyclic or a heterocyclic united with an unsubstituted or substituted aryl having cholecystokinine antagonistic activity.
    Type: Grant
    Filed: December 27, 1989
    Date of Patent: January 29, 1991
    Assignee: Roussel Uclaf
    Inventors: Jean-Claude Gasc, Daniel Humbert
  • Patent number: 4929269
    Abstract: Compounds of the formula ##STR1## and salts thereof, W and W, being independently O and S, A being a nitrogen-containing heterocyclic ring system, E being O, S(O)m or NR.sub.3 where m is 0-2, R.sub.1, R.sub.2 and R.sub.3 is hydrogen, C.sub.1 -C.sub.4 alkyl or C.sub.2 -C.sub.4 alkenyl or alkynyl and E.sub.1 being hydrogen, halogen or one of a variety of organic substituents.The compounds are effective herbicides.
    Type: Grant
    Filed: October 19, 1988
    Date of Patent: May 29, 1990
    Assignee: ICI Australia Operations Proprietary Limited
    Inventors: Keith G. Watson, Peter Drygala, Stephen Bell